Literature DB >> 1333761

Naturally occurring-neutralizing monoclonal antibody escape variants define the epidemiology of infectious bursal disease viruses in the United States.

D B Snyder1, V N Vakharia, P K Savage.   

Abstract

A panel of two non-neutralizing and six neutralizing monoclonal antibodies (Mabs) were used in antigen-capture enzyme immunoassays (AC-ELISA) to examine the antigenicity of 1301 wild type infectious bursal disease viruses (IBDV) isolated from different poultry flocks throughout the United States over a three year period. Analysis of these isolates with protective, neutralizing Mabs directed against the VP2 structural protein of IBDV showed that four antigenically distinct groups of serotype 1 IBDV could be separated on the basis of the presence or absence of one or more Mab defined, conformation-dependent, multivalent neutralization site. AC-ELISA reactivity patterns of the Mabs with isolates demonstrated that IBDV field populations were relatively antigenically homogeneous per premise isolation. Geographically, various antigenic species were more or less prevalent, or nearly absent. Competition analysis with neutralizing Mabs coupled with AC-ELISA results suggested that neutralization epitopes for IBDV are distinct, spatially arranged, yet closely linked. Of 5 Mab defined neutralization epitopes, shown to be related to protection from virulent challenge by Classic IBDV strains isolated prior to 1985, only two of the epitopes remain unaltered on the most recent emergent variant field strain of IBDV isolated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1333761     DOI: 10.1007/bf01309577

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  13 in total

1.  Differentiation of infectious bursal disease viruses directly from infected tissues with neutralizing monoclonal antibodies: evidence of a major antigenic shift in recent field isolates.

Authors:  D B Snyder; D P Lana; P K Savage; F S Yancey; S A Mengel; W W Marquardt
Journal:  Avian Dis       Date:  1988 Jul-Sep       Impact factor: 1.577

2.  Antigenic diversity of infectious bursal disease viruses.

Authors:  D H Jackwood; Y M Saif
Journal:  Avian Dis       Date:  1987 Oct-Dec       Impact factor: 1.577

3.  Virus-neutralizing and passively protective monoclonal antibodies to infectious bursal disease virus of chickens.

Authors:  K J Fahey; P McWaters; M A Brown; K Erny; V J Murphy; D R Hewish
Journal:  Avian Dis       Date:  1991 Apr-Jun       Impact factor: 1.577

4.  Infectious bursal disease virus variant from commercial Leghorn pullets.

Authors:  N M Ismail; Y M Saif; W L Wigle; G B Havenstein; C Jackson
Journal:  Avian Dis       Date:  1990 Jan-Mar       Impact factor: 1.577

5.  Group and strain-specific neutralization sites of infectious bursal disease virus defined with monoclonal antibodies.

Authors:  D B Snyder; D P Lana; B R Cho; W W Marquardt
Journal:  Avian Dis       Date:  1988 Jul-Sep       Impact factor: 1.577

6.  Biophysical and biochemical characterization of five animal viruses with bisegmented double-stranded RNA genomes.

Authors:  P Dobos; B J Hill; R Hallett; D T Kells; H Becht; D Teninges
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

7.  Characteristics and serologic studies of two serotypes of infectious bursal disease virus in turkeys.

Authors:  D J Jackwood; Y M Saif; J H Hughes
Journal:  Avian Dis       Date:  1982 Oct-Dec       Impact factor: 1.577

8.  Acute infectious bursal disease in poultry: Isolation and characterisation of a highly virulent strain.

Authors:  T P Berg; M Gonze; G Meulemans
Journal:  Avian Pathol       Date:  1991-03       Impact factor: 3.378

9.  Comparative studies on structural and antigenic properties of two serotypes of infectious bursal disease virus.

Authors:  H Becht; H Müller; H K Müller
Journal:  J Gen Virol       Date:  1988-03       Impact factor: 3.891

10.  Isolation and serological studies with infectious bursal disease viruses from fowl, turkeys and ducks: demonstration of a second serotype.

Authors:  J B McFerran; M S McNulty; E R McKillop; T J Connor; R M McCracken; D S Collins; G M Allan
Journal:  Avian Pathol       Date:  1980-07       Impact factor: 3.378

View more
  12 in total

1.  Molecular determinants of virulence, cell tropism, and pathogenic phenotype of infectious bursal disease virus.

Authors:  M Brandt; K Yao; M Liu; R A Heckert; V N Vakharia
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Antigenic and molecular characterization of recent infectious bursal disease virus isolates in China.

Authors:  Jue Liu; Jiao Zhou; Jimmy Kwang
Journal:  Virus Genes       Date:  2002-03       Impact factor: 2.332

3.  A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV.

Authors:  Zhuhui Huang; Subbiah Elankumaran; Abdul S Yunus; Siba K Samal
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

4.  Nonstructural protein of infectious bursal disease virus inhibits apoptosis at the early stage of virus infection.

Authors:  Meihong Liu; Vikram N Vakharia
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

5.  Expression of immunogenic VP2 protein of infectious bursal disease virus in Arabidopsis thaliana.

Authors:  H Wu; N K Singh; R D Locy; K Scissum-Gunn; J J Giambrone
Journal:  Biotechnol Lett       Date:  2004-05       Impact factor: 2.461

6.  Molecular and structural bases for the antigenicity of VP2 of infectious bursal disease virus.

Authors:  Tobias Letzel; Fasseli Coulibaly; Felix A Rey; Bernard Delmas; Erik Jagt; Adriaan A M W van Loon; Egbert Mundt
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

7.  Protective vaccination against infectious bursal disease virus with whole recombinant Kluyveromyces lactis yeast expressing the viral VP2 subunit.

Authors:  Marina Arnold; Vijay Durairaj; Egbert Mundt; Katja Schulze; Karin D Breunig; Sven-Erik Behrens
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

8.  Effects of DDA, CpG-ODN, and plasmid-encoded chicken IFN-gamma on protective immunity by a DNA vaccine against IBDV in chickens.

Authors:  Ha Jung Roh; Haan Woo Sung; Hyuk Moo Kwon
Journal:  J Vet Sci       Date:  2006-12       Impact factor: 1.672

9.  Characterization of variant infectious bursal disease virus from a broiler farm in Japan using immunized sentinel chickens.

Authors:  Kenichi Yamazaki; Hideyuki Ohta; Toru Kawai; Tsuyoshi Yamaguchi; Takeshi Obi; Kozo Takase
Journal:  J Vet Med Sci       Date:  2016-10-27       Impact factor: 1.267

10.  Protection of chicken against very virulent IBDV provided by in ovo priming with DNA vaccine and boosting with killed vaccine and the adjuvant effects of plasmid-encoded chicken interleukin-2 and interferon-gamma.

Authors:  Jeong Ho Park; Haan Woo Sung; Byung Il Yoon; Hyuk Moo Kwon
Journal:  J Vet Sci       Date:  2009-06       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.